A Kyoto University team has produced T-cell precursor cells from human iPS cells and shown that, once transplanted into mice, they settle in the thymus and mature into working T cells, Kyodo News reported.
The team announced the results in a US science journal dated November 21. The cells are T precursor cells, the raw material the thymus — the organ near the heart that acts as a school for immune cells — uses to raise T cells.
T cells attack foreign bodies in the body. A shortage of T precursor cells reaching the thymus is considered one cause of congenital immune deficiency and of the high susceptibility to infection after bone marrow transplants.
Research on making T cells from iPS cells for treatment is advancing. But such cells can be aimed only at specific pathogens or cancer cells.
To handle a wide range of foreign bodies, researchers have considered mass-producing T precursor cells and transplanting them. The body would then mature them into T cells that react to many different targets.
The team adjusted the culture conditions and added mainly two reagents to give the cells sufficient stimulation. Under those conditions, the team showed, iPS cells yield T precursor cells efficiently.